Skip Navigation

Oregon State University

Superfund Research Program

Linking PAH Exposure to Health Outcomes Using Human Primary In Vitro Respiratory Model

Project Leader: Susan C. Tilton
Co-Investigator: David E. Williams
Grant Number: P42ES016465
Funding Period: 2009-2025
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Project-Specific Links

Connect with the Grant Recipients

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Facebook page Visit the grantee's Video page

Project Summary (2020-2025)

One of the most difficult challenges for environmental health is to evaluate hazards from exposure to chemical mixtures. The environmental health science community recognizes a growing need to evaluate toxicity for structurally diverse PAHs and their transformation and breakdown products in complex mixtures, using human-relevant and metabolically competent research models. This Biomedical Science Research Project will assess the toxicity of PAHs in complex mixtures associated with Superfund sites in a 3D human lung model composed of primary human bronchial epithelial cells (HBEC) differentiated at the air-liquid interface. This project will quantify the toxicity of PAHs and PAH mixtures targeting lungs via endpoints relevant for multiple exposure routes (inhalation, diet, dermal). Susan Tilton, Ph.D., and her team will rely on benchmark dose modeling to identify a threshold response for comparison and will apply integrated RNAseq and functional proteomics to identify mechanisms by which PAHs exert adverse health outcomes in exposed populations and to identify susceptible individuals in those populations. The overall goal of this project is to understand how individual PAHs contribute to toxicity in mixtures and to establish a relationship between chemical exposure and toxicity. The outcomes of these studies will be applied to assess and communicate human health risk and to evaluate susceptibility for relevant populations. To achieve these aims the research team will: 1) quantify the toxicity of PAHs and PAH mixtures in the 3D lung model, 2) assess the role of metabolism on the toxicity of individual PAHs in the 3D human lung model and 3) elucidate the mechanisms of PAH toxicity in the 3D human lung model.

to Top